AI is reshaping drug discovery and development, and Israel is emerging as a proving ground for real-world impact. This session brings together pharma leaders, global tech leaders, investors, and startups to showcase where AI is already delivering value. Through case studies and expert insights, the discussion will explore what it takes to move beyond hype, build effective collaborations, and translate AI-driven innovation into measurable breakthroughs for global pharma.